Research summary
Berberine Dosage
Quick answer
Amounts depend on the study and outcome. One 120-day trial in adults with type 2 diabetes reported 1,000 mg/day of berberine in both a Berberis-extract group and a Berberis/Silybum-combination group, alongside existing care. That protocol is not a personal dosing recommendation. Modeled dose-response findings do not establish an optimal regimen.[1], [2], [3]
What does the evidence support?
Read each finding with its qualification. These are source-supported statements, not a ranking of products or personal treatment advice.
| Finding and qualification | References |
|---|---|
| In a small single-blind randomized trial alongside existing diabetes care, a fixed berberine-containing Berberis/Silybum combination reduced HbA1c more than Berberis extract alone; fasting-glucose and lipid between-group differences were not statistically significant. The 120-day study had 63 completers and variable background care. It does not establish a preferred supplement stack, an absorption mechanism, or a reason to alter prescribed treatment. One author disclosed formulation/patent inventorship. The paper describes the Silybum constituent inconsistently, so no precise silymarin dose is inferred. | [1] |
| A nonlinear dose-response analysis reported reductions in IL-6 and TNF-α with berberine/barberry interventions at reported doses below 1,000 mg/day and durations below five weeks. This modeled association concerns inflammatory biomarkers. It does not describe the most commonly used trial dose, prove an optimal amount, or establish meal timing or divided-dose instructions. | [2] |
| A dose-response meta-analysis of randomized trials reported that the magnitude of berberine's measured effects varied with the dose and the duration of supplementation. Associations across heterogeneous trials do not establish an optimal dose or duration for an individual. Formulations and populations differed across studies. | [2], [3] |
A concrete studied protocol
The 120-day single-blind trial had 63 completers with type 2 diabetes. It compared a reported 1,000 mg/day of berberine in two botanical preparations. Background care varied; the study does not establish a general-purpose dose or justify changing diabetes medicines.[1]
A modeled threshold is not a recommended dose
A nonlinear analysis of berberine/barberry interventions reported IL-6 and TNF-α reductions below 1,000 mg/day and below five weeks. Those are modeled associations, not a count of which doses were most often used or a test of meal timing.[2]
Different outcomes require separate protocol interpretation
One pooled analysis reported a reduction in waist circumference, but the supporting studies had notable quality and heterogeneity limitations.[3]
An amount associated with waist circumference cannot automatically be treated as the best amount for fasting glucose, body weight, PCOS, blood lipids, or another endpoint.[2], [3]
Do divided doses or enhanced formulations establish a better regimen?
Protocols around 1,000–1,500 mg daily appear in the lipid trials, often split into two or three doses, but that describes what was tested in adults with diabetes or hyperlipidemia. It does not determine the best schedule for a different goal. The dose-response analyses combine heterogeneous formulations and populations; a modeled threshold is not a personalized instruction.[2], [3], [4], [5]
A small 120-day trial compared a Berberis/Silybum combination with Berberis extract while existing diabetes care continued. Although the HbA1c comparison favored the combination, fasting glucose and lipid differences did not. That finding does not establish a preferred supplement stack or prove an absorption mechanism, and the paper’s inconsistent Silybum description prevents a precise inferred dose.[1]
References
- Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes. Clinical pharmacology : advances and applications. 2013. Primary study View source →
- Effects of berberine and barberry on selected inflammatory biomarkers in adults: A systematic review and dose-response meta-analysis of randomized clinical trials.. Phytotherapy research : PTR. 2023. Systematic review and meta-analysis View source →
- The effect of berberine supplementation on obesity indices: A dose- response meta-analysis and systematic review of randomized controlled trials.. Complementary therapies in clinical practice. 2020. Systematic review and meta-analysis View source →
- The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. Oxidative medicine and cellular longevity. 2021. Systematic review and meta-analysis View source →
- Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.. Journal of ethnopharmacology. 2015. Systematic review and meta-analysis View source →
Frequently asked questions
What berberine doses have been studied?
Amounts depend on the study and outcome. One 120-day trial in adults with type 2 diabetes reported 1,000 mg/day of berberine in both a Berberis-extract group and a Berberis/Silybum-combination group, alongside existing care. That protocol is not a personal dosing recommendation.
Read the full FAQ and limitations →